Business
Grant received from the Bill and Melinda Gate...
Grant received from the Bill and Melinda Gate....
About this update from 4basebio Plc
[{"type":"text","content":"\n\n \n \n\n\n\n\n 1 August 2023\n4basebio PLC\n(\"4basebio\", the \"Company\" or the \"Group\")\n4basebio receives grant to advance its synthetic DNA platform and Hermes™ nanoparticle platform for the development of\nthermostable nucleic acid vaccines\n\nFunding from the Bill & Melinda Gates Foundation will build on preclinical data demonstrating superior immune responses achieved with 4basebio's synthetic DNA products as well as improved stability offered by its Hermes™ platform.Cambridge, UK, 1 August 2023 - 4basebio PLC (AIM: 4BB), an innovation driven biotechnology company enabling and accelerating development of advanced therapy medicinal products (ATMPs) through its high performant synthetic DNA products and non-viral, thermostable nucleic acid delivery platform, today announces it has received a grant from the Bill & Melinda Gates Foundation (the \"Foundation\") to advance the development program of thermostable nucleic acid based vaccines.\nThe development program aims to build on preclinical data demonstrating the improved stability offered by the Hermes™ platform, the superior immune responses achieved with 4basebio's synthetic DNA products and high-quality mRNA produced from 4basebio opDNA™ products.\nThe successful demonstration of the Hermes™ platform and 4basebio synthetic nucleic acid payloads in infectious disease vaccines has the potential to enhance the global availability of such innovative medicines.\nHeikki Lanckriet, CEO and CSO of 4basebio, commented: \"The Foundation's grant recognises the potential of our Hermes™ and synthetic DNA platforms. The enhanced stability offered by our vectors as well as the rapid turnaround time offered through our synthetic DNA has the potential to enable a faster response to pandemic needs and create highly performant and affordable vaccine products in support of the global fight against infectious diseases.\"\nFor further enquiries, please contact:\n4basebio PLC &n...